Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Cytotoxic T lymphocytes against HIV.

Walker BD, Plata F.

AIDS. 1990 Mar;4(3):177-84. Review.

PMID:
1693514
2.

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.

Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T, et al.

Nat Med. 1995 Jan;1(1):59-64. Erratum in: Nat Med 1995 Jun;1(6):598.

PMID:
7584954
3.

Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.

Plata F, Dadaglio G, Chenciner N, Hoffenbach A, Wain-Hobson S, Michel F, Langlade-Demoyen P.

Immunodefic Rev. 1989;1(3):227-46. Review.

PMID:
2698642
7.

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.

Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'Aquila RT, Kurnick JT, Walker BD.

J Exp Med. 1994 Apr 1;179(4):1261-71.

8.

Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.

van Baalen CA, Guillon C, van Baalen M, Verschuren EJ, Boers PH, Osterhaus AD, Gruters RA.

Eur J Immunol. 2002 Sep;32(9):2644-52.

9.

HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.

Zhai S, Zhuang Y, Song Y, Li S, Huang D, Kang W, Li X, Liao Q, Liu Y, Zhao Z, Lu Y, Sun Y.

Curr HIV Res. 2008 Jun;6(4):335-50.

PMID:
18691032
10.

The cytotoxic T-lymphocyte response in HIV-1 infection.

Kalams SA, Walker BD.

Clin Lab Med. 1994 Jun;14(2):271-99. Review.

PMID:
7924192
11.

Cytotoxic T lymphocytes specific for the simian immunodeficiency virus.

Letvin NL, Schmitz JE, Jordan HL, Seth A, Hirsch VM, Reimann KA, Kuroda MJ.

Immunol Rev. 1999 Aug;170:127-34. Review.

PMID:
10566147
12.

Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.

Koziel MJ, Walker BD.

Springer Semin Immunopathol. 1997;19(1):69-83. Review.

PMID:
9266632
13.

NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.

Fauci AS, Gallo RC, Koenig S, Salk J, Purcell RH.

Ann Intern Med. 1989 Mar 1;110(5):373-85. Review.

PMID:
2464961
14.

Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.

Nehete PN, Chitta S, Hossain MM, Hill L, Bernacky BJ, Baze W, Arlinghaus RB, Sastry KJ.

Vaccine. 2001 Dec 12;20(5-6):813-25.

PMID:
11738745
17.

Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.

Tomiyama H, Miwa K, Shiga H, Moore YI, Oka S, Iwamoto A, Kaneko Y, Takiguchi M.

J Immunol. 1997 May 15;158(10):5026-34.

PMID:
9144523
18.

Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.

Goulder P, Price D, Nowak M, Rowland-Jones S, Phillips R, McMichael A.

Immunol Rev. 1997 Oct;159:17-29. Review.

PMID:
9416500
19.

Implications of HIV-specific cytotoxic T lymphocytes in AIDS.

Plata F.

Biotherapy. 1992;5(1):31-45. Review.

PMID:
1389901

Supplemental Content

Support Center